A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Ljubenkov, MD
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lawson Health Research Institute, St. Joseph'S
London, Ontario, Canada
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Technical University of Munich
München, Germany
- University of Ulm
Ulm, Germany
- University of Brescia
Brescia, Italy
- Brain Research Center - Ppds
Amsterdam, Netherlands
- Erasmus University Medical Center
Rotterdam, Netherlands
- University College London
London, United Kingdom
- Ucsf
San Francisco, California, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- the Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases Ut Health San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Sept 2019
- Primary completion
- 5 Jun 2024
- Completion
- 5 Jun 2024
- Last update posted
- 5 Dec 2025
- Registered enrollment
- 33
- Registry id
- NCT03987295
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.